Efficacy and Safety of Small Molecule Inhibitor Therapies for Vitiligo: A Systematic Review

JAKI and SMIs appear to be promising treatment options for vitiligo in adults, adolescents, and children, offering better efficacy than traditional treatments. However, some treatments like Apremilast had conflicting results about efficacy in vitiligo. Although these are notable findings, further research is required to establish their long-term safety, particularly in children and adolescents.